drugset
drugset / Trial / NCT03928496

Abobotulinumtoxina Efficacy in Post-Traumatic Headache

NCT03928496 ↗

Phase 4 Completed 40 enrolled VA Greater Los Angeles Healthcare System Ipsen · collab
RandomizedCrossoverDouble-blindTreatment

Summary

This study will evaluate the efficacy of abobotulinumtoxina on Veterans with post-traumatic headache

Timeline

Start
2013-08-01
Primary completion
2017-02-02
Completion
2017-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 300 iu Intramuscular

Indications

traumatic encephalopathy